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Abstract
Emerging research implicates the participation of spinal dorsal horn (SDH) neurons and astrocytes in nerve injury-induced
neuropathic pain. However, the crosstalk between spinal astrocytes and neurons in neuropathic pain is not clear. Using a
lumbar 5 (L5) spinal nerve ligation (SNL) pain model, we testified our hypothesis that SDH neurons and astrocytes
reciprocally regulate each other to maintain the persistent neuropathic pain states. Glial fibrillary acidic protein (GFAP) was
used as the astrocytic specific marker and Fos, protein of the protooncogene c-fos, was used as a marker for activated
neurons. SNL induced a significant mechanical allodynia as well as activated SDH neurons indicated by the Fos expression at
the early phase and activated astrocytes with the increased expression of GFAP during the late phase of pain, respectively.
Intrathecal administration of c-fos antisense oligodeoxynucleotides (ASO) or astroglial toxin L-a-aminoadipate (L-AA)
reversed the mechanical allodynia, respectively. Immunofluorescent histochemistry revealed that intrathecal administration
of c-fos ASO significantly suppressed activation of not only neurons but also astrocytes induced by SNL. Meanwhile, L-AA
shortened the duration of neuronal activation by SNL. Our data offers evidence that neuronal and astrocytic activations are
closely related with the maintenance of neuropathic pain through a reciprocal ‘‘crosstalk’’. The current study suggests that
neuronal and non-neuronal elements should be taken integrally into consideration for nociceptive transmission, and that
the intervention of such interaction may offer some novel pain therapeutic strategies.
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Introduction
Peripheral nerve injury often results in neuropathic pain [1]
which is essentially intractable to currently available anti-
nociceptive therapies. This is in part due to poor understanding
on how neuropathic pain is induced and maintained [2].
According to classic pain research, the pain pathway has been
described simply as a serial chain of neuronal elements, but
immerging research has implicated spinal cord glial cells as key
players in the induction and maintenance of neuropathic pain [3].
Due to the immune cell nature of microglia and their ability of
releasing the ‘‘proinflammatory’’ cytokines such as interlukin-1
(IL-1), tumor necrosis factor (TNF) and adenosine triphosphate
(ATP) when activated [4,5,6,7,8], microglia receive intensive focus
in pain research, especially persistent pain after inflammation or
nerve injury [9,10,11,12]. Thanks to decades of pain researchers’
endeavors, the underlying mechanisms for microglia-neuron
interaction and its contribution to neuropathic pain have almost
been clarified [13]. However, the spinal astrocytes, which are
more dominant than microglia, are majorly investigated for its
supportive and tropic functions for neurons [14,15] instead of their
contributions to neuropathic pain. A few studies suggested the
activation of spinal astrocytes during neuropathic pain
[3,13,16,17], but it is not clear whether there exists astrocyte-
neuron crosstalk just as in the case of microglia, and how this
happens [18].
C-fos, as a protooncogene, has been shown to act as an inducible
transcriptional factor and suggested to regulate the expression of
the downstream response genes [6,19,20]. Fos protein is rapidly
expressed in the spinal dorsal horn neurons following noxious
peripheral nerve stimulation [21] and correlates well with
nociceptive behaviors [19]. Thus, Fos expression is used to
identify nociceptive input activated or excited population of
neurons [22,23,24].
Astrocytes can sensitively and rapidly respond to various
physiological or noxious stimuli with the increased expression of
glial fibrillary acidic protein (GFAP), thus be used as a marker for
astrocytic activation [25]. Our previous research indicates that
GFAP upregulation correlates well with nerve injury-induced
neuropathic pain [26]. However, astrocytes cannot generate
action potential and are not able to contribute to the nociceptive
transmission alone and directly [14]. Hence, a hypothesis is that
the activated astrocytes and neurons are ‘‘crosstalking’’ so as to
contribute to the neuropathic pain states [27]. However, there still
lacks direct evidence for this hypothesis.
To achieve this goal, it is necessary to shut-down the activated
astrocytes or neurons to elucidate their individual contribution to
neuropathic pain. In the current study, L-a-aminoadipate (L-AA)
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disruption of the astrocytic network in amygdala is confined to
astrocytes [28,29]. C-fos antisense oligodeoxynucleotides (ASO)
was used in our previous studies and the corresponding
nociceptive behavioral changes were observed as a consequence
of knocking down its protein product [24,30,31,32], thus, it was
employed in this study to shut down activated neurons.
In the current study, we observed the temporal activation of
neurons and astrocytes along with lumbar 5 spinal nerve ligation
(SNL) induced neuropathic pain behaviors by using Fos or GFAP
expression, respectively. Then, the effect of intrathecal (i.t.)
injection of c-fos ASO or L-AA on pain behaviors as well as
neuronal or astrocytic activation was identified morphologically.
The possible ‘‘crosstalk’’ between astrocytes and neurons was
investigated by checking the effect of inhibited activation of one
type of cells on the other.
Results
SNL-induced mechanical allodynia was reversed by c-fos
ASO or L-AA treatment
SNL-induced neuropathic pain is characterized by ipsilateral
mechanical allodynia [33]. Previous studies indicated that SNL
produced rapidly appearing (,3 d) and persistent (.3w )
ipsilateral mechanical allodynia shown by decrease of paw
withdrawal threshold (PWT) [17,26].
C-fos ASO treatment significantly reversed mechanical allody-
nia in 3 d post SNL. The ASO treatment and post operative day
(POD) had significant effect on the SNL-induced ipsilateral
allodynia [Fig. 1A; two way ANOVA (between subjects factors:
Group and Day): Group: F (2,326)=127.314, P=0.000; Day: F
(7,326)=209.909, P=0.000; Group*Day: F (14,326)=9.676,
P=0.000]. The effect of SNL on the allodynia of saline and SO
groups was incubated with time. SNL rats in saline and c-fos SO
group demonstrated significant ipsilateral allodynia 1 d after the
surgery (PWT=6.861.3 g and 7.460.6 g on POD 1 for Saline
and SO groups, respectively; Post hoc test, P,0.05, vs correspond-
ing baseline for saline and SO group, respectively) and the
ipsilateral allodynia reached a high level on POD 3 and lasted for
the whole observing window. There was no significant difference
between saline and SO group at every corresponding time point.
Treatment with ASO significantly reversed the ipsilateral
allodynia on POD 1 (PWT=6.861.3 g, 7.460.6 g, 20.462.3 g
at POD 1 for Saline, SO and ASO group, respectively; Post hoc
test, P,0.01, vs Saline or SO group), and such reversal effect
existed for the whole observing window (Post hoc test, P,0.01, for
2, 3, 4, 5 and P,0.05 for 6 and 7 days after SNL, vs Saline or SO
group). But the preventing effect weakened gradually. On POD 4,
PWT in the Saline group was 3.460.4 g, while it was 10.861.6 g
in the ASO group. And the difference of PWT between groups
was much less but still significant 7 d after SNL (Fig. 1A). Thus,
SNL itself produced a significant allodynia which was incubated
with time; SO treatment did not change the neuropathic pain
performance after SNL, while ASO treatment reversed the SNL-
induced neuropathic pain with a long-lasting effect.
Treatment with the astrocyte inactivator L-AA, reversed
mechanical allodynia only at the late stage. The L-AA treatment
and POD had significant effect on the SNL-induced ipsilateral
allodynia [Fig. 1B; two way ANOVA (between subjects factors:
Group and Day): Group: F (1,216)=157.194, P=0.000; Day: F
(7,216)=94.389, P=0.000; Group*Day: F (7,216)=11.567,
p=0.000]. Treatment with L-AA significantly reversed the
ipsilateral allodynia on POD 3 (PWT=4.760.8 g and 12.461.4 g
for Saline and L-AA groups, respectively; Post hoc test, P,0.01), and
such reversal effect existed since POD 3 (Post hoc test, P,0.01 for
POD 4 and 5 and P,0.05 for POD 6 and 7, vs saline group). On
POD 7, the PWTs for saline and L-AA groups were 3.460.5 g and
8.861.6 g, respectively. Inactivation of astrocytes by L-AA
selectively reversed mechanical allodynia 7 d post nerve injury.
In the sham-operated animals, PWTs was not influenced
compared with that of naı ¨ve rats. Furthermore, intrathecal
injection of c-fos ASO, SO or L-AA on sham-operated rats did
not change their PWTs (data not shown).
SNL enhanced Fos and GFAP expression in the ipsilateral
spinal dorsal horn
Immunofluorescent histochemistry was employed to demonstrate
the Fos expression from different groups (Fig. 2A, A’). To rule out
Figure 1. Effects of intrathecal administration of c-fos ASO (A)
or L-AA (B) on SNL-induced mechanical allodynia. A, SNL rats in
saline and c-fos SO group demonstrated significant ipsilateral allodynia
since 1 d after the surgery. Intrathecal administration of c-fos ASO
(50 mg/10 ml, starting 4 h prior to the surgery and once a day for a
further 3 d following surgery) significantly reversed the ipsilateral
allodynia. The preventing effect of ASO weakened gradually but still
significant 7 d after SNL B, Intrathecal administration of astroglial toxin
L-AA (100 nmol/10 ml, injected daily from 1 d before till 3 d after the
surgery) reversed mechanical allodynia only at the late stage. The data
are presented as the mean 6 S.E.M. * and ** indicate statistically
significant difference with P,0.05 and P,0.01 compared to saline
control of each time point, respectively.
doi:10.1371/journal.pone.0006973.g001
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immunoreactive (IR) neuronswasnormalized tothat innaı ¨verats at
corresponding time points. SNL induced a significant increase of
Fos expression in the ipsilateral but not the contralateral spinal
dorsal horn (Fig. 2A, A’). A time-course study showed that the Fos
expression reached the highest level 2 h after SNL, then declined
gradually, to normal level by 1 w (Fig. 2D, 5D). Almost all of the
Fos-IR cells were neurons as indicated by NeuN staining (95% of
Fos-IR neurons were also positive for NeuN, Fig. 3). SNL-induced
Fos expression was restricted to the neuronal population as the ratio
of Fos positive NeuN-IR cells to Fos-IR did not vary too much
among different groups nor at different time points. Thus, increased
Fos expression was reliably used as an marker for activated neurons
but not astrocytes. Meanwhile, most of the Fos-IR neurons were
observed in laminae I and II with a few in laminae III and IV and
some in laminae V and VI of the dorsal horn (Fig. 2A), suggesting
most of them were nociceptive neurons.
Similar to our previous observation [26], SNL induced a
marked expression of GFAP in the ipsilateral but not the
contralateral dorsal horn (Fig. 2B). A time course study showed
that GFAP up-regulation was not evident on POD 1, but became
significant on POD 3, and reached a peak on POD 7 after SNL
(Fig. 4D, 5D). Double immunofluorescent labeling indicated that
few GFAP-IR cells were positive for Fos, while most of them were
overlapped nuclei of activated neurons (Fig. 4). These activated
astrocytes were mainly distributed in the superficial laminae of
dorsal horn ipsilateral to the injury, suggesting a role in the
nociceptive transmission. The Fos-IR neurons were surrounded
with many GFAP-IR astrocytic processes, forming many close
contacts (Fig. 3B’).
C-fos ASO treatment suppressed SNL-induced neuronal
and astrocytic activations in different manners
Besides its effect on the SNL-induced ipsilateral mechanic
allodynia, c-fos ASO significantly inhibited SNL-induced Fos
protein expression in the ipsilateral dorsal horn. Statistical analysis
revealed a significant effect of treatment as well as POD on the
SNL induced dorsal horn Fos expression [Fig. 4D; two way
ANOVA (between subjects factors: Group and Day): Group: F (2,
36)=117.717, P=0.000; Day: F (3, 36)=85.247, P=0.000;
Group*Day: F (6, 36)=20.944, P=0.000]. Inhibition of ASO
on SNL-induced Fos expression occured right after the nerve
injury (at 2 h after SNL). The Fos expression level in ASO group
was almost the same as baseline and this effect lasted during the
whole observing window (Fig. 4D).
Meanwhile, c-fos ASO also inhibited the SNL-induced GFAP
up-regulation but such effect was different from that on Fos
expression. According to our previous study [26], SNL-enhanced
GFAP expression occurs later than POD 3. Statistical analysis
revealed a significant effect of treatment as well as POD on the
SNL-induced GFAP up-regulation [Fig. 4D; two way ANOVA
(between subjects factors: Group and Day): Group: F (2,
36)=6.930, P=0.004; Day: F (3, 36)=103.403, P=0.000;
Group*Day: F(6, 36)=2.204, P=0.078]. ASO treatment rendered
inhibitory effect on the enhanced GFAP on POD 3 and 7. Our
changing course study of GFAP expression in the ipsilateral SDH
of Saline, as well as for c-fos SO and ASO groups indicated that
there were no obvious differences at 2 h and POD 1 when no
obvious astrocytic activation could be detected (Fig. 4D). While the
mean immunofluorescence density of the GFAP signal was
significantly suppressed by ASO on POD 3 and 7, when the
astrocytic activation in the ipsilateral dorsal horn was at a very
high level in the saline control group (Fig. 4C).
L-AA treatment down-regulated SNL-induced astrocytic
and neuronal activations in different manners
Intrathecal injection of an astrocytic toxin, L-AA, produced
analgesic effect on SNL-induced mechanical allodynia. As
demonstrated above, this effect was significant during the late
stage of the mechanic allodynia. Such behavioral change was
Figure 2. Immunofluorescent staining for Fos and GFAP in the spinal dorsal horn after SNL. A–A’, SNL induced a significant up-
regulation of Fos expression in the ipsilateral dorsal horn 2 h after SNL. B–B’, GFAP immunoreactive astrocytes were significantly activated 1 w after
nerve injury in the ipsilateral compared to the contralateral dorsal horn. Scale bar=200 mm.
doi:10.1371/journal.pone.0006973.g002
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enhanced GFAP expression. Statistical analysis revealed a
significant effect of treatment as well as POD on the SNL-induced
GFAP expression [Fig. 5D; two way ANOVA (between subjects
factors: Group and Day): Group: F (1, 24)=94.917, P=0.000;
Day: F (3, 24)=157.417, P=0.000; Group*Day: F(3,
24)=28.865, P=0.000]. L-AA treatment rendered inhibitory
effect on the enhanced-GFAP on POD 3 and 7 compared to the
saline control). Our changing course study of GFAP expression in
the ipsilateral superficial dorsal horn of Saline and L-AA groups
indicated that there were no obvious differences at 2 h and POD 1
when no obvious astrocytic activation could be detected (Fig. 5D).
The effect of L-AA appeared to be astrocytic specific, because it
only reduced the number of GFAP-expressing astrocytes, but not
that of NeuN-expressing neurons (Fig. 5B).
To our surprise, although the total number of NeuN-positive
neurons did not change under either SNL or SNL + L-AA
treatment, the activation of neurons was suppressed by L-AA
treatment, possibly via an indirect way other than L-AA’s direct
impairment to neurons. Statistical analysis revealed a significant
effect of treatment as well as POD on the SNL induced SDH Fos
expression [Fig. 5D; two way ANOVA (between subjects factors:
Group and Day): Group: F (1, 24)=5.284, P=0.035; Day: F (3,
24)=35.764, P=0.000; Group*Day: F (3, 24)=1.359, P=0.291].
L-AA treatment rendered inhibitory effect on the enhanced Fos
expression on POD 1 and 3. Studies on Fos expression in the
ipsilateral superficial dorsal horn of saline controls and L-AA
groups indicated that there were no obvious differences at 2 h
when significant astrocytic activation could not be detected
(Fig. 5D). The Fos expression of the L-AA group dropped to the
Figure 3. Double immunofluorescence for Fos (red)/NeuN (green) and Fos (red)/GFAP (green) in the ipsilateral dorsal horn 3 d after
SNL. A’ and B’ are the magnified images of the rectangles indicated in the above top panels in A and B, respectively. Double immunofluorescence
indicated that few GFAP-IR astrocytes were Fos positive (shown by double arrowheads in B’), while most of them were nuclei of activated neurons
(shown by double arrowheads in A’). These activated neurons and astrocytes were mainly distributed in the superficial layer of dorsal horn, and the
Fos-positive neurons were surrounded with many GFAP-positive astrocytic processes formed close relationship with each other. The figures shows
representative photomicrographs obtained from a minimum of three independent experiments. Fos and NeuN double labeled neurons observed in
the ipsilateral superficial dorsal horn were counted and the proportion of double labeling neurons in total Fos positive cells were calculated. The
statistical results of these comparisons are presented in C. Scale bar=200 mm in A, B and 80 mm in A’ and B’.
doi:10.1371/journal.pone.0006973.g003
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7 in saline control animals. These data indicated that this astroglial
toxin did not change the peak value but shorten the duration of
neuronal activation (Fig. 5C, D).
In the sham-operated animals, neuronal and astrocytic
activation was not influenced compared with that of naı ¨ve rats.
Furthermore, intrathecal injection of c-fos ASO, SO or L-AA on
sham-operated rats did not change the expression of Fos and
GFAP (data not shown).
Discussion
In this study, we examined the relationship between nerve
injury-induced mechanical allodynia, neuronal and astrocytic
activation, and there interactions. Our findings established that:
(1) Inhibiting either neuronal or astrocytic activity prevented SNL
induced neuropathic pain; (2) Astrocytic activation is downstream
to the activation of neurons; (3) Astrocytic activation can enhance
neuronal activation. Concluding from the above results, we
hypothesize that there is a positive feedback circuit for neuronal-
glial interaction under neuropathic pain states.
Neuronal and astrocytic activation emerges mainly in
induction and maintenance of allodynia, respectively
Allodynia is one of the clinically common symptoms which
affect the patients’ life quality severely. It is usually described in
two different stages: induction (or initiation, usually occurs within
3 d after nerve injury in animal models) and maintenance (or
duration, usually occurs later than 3 d post nerve injury).
Figure4.TheexpressionsofFosandGFAP intheipsilateraldorsalhorninsaline,c-fosSOandASOgroupsafterSNL.Comparedtosaline
or c-fos SO treated group, c-fos ASO produced a significantinhibitory effect on Fos protein expression (A–A0), as well as on astrocytic activation(B–B0,C –
C0) in thespinal dorsal horn. D, Statistics of thetime coursestudy.Thebaseline level ofFos andGFAP was setas 100%,respectively. Thechangingcourse
of Fos (red curves) or GFAP (green curves) was determined with comparison to the relative baseline value. The relative increase in the number of Fos-
positive neurons reached a peak 2 h in the SO and saline group, then fell back quickly to the normal level in 1 w. However, Fos expression was
maintained at the baseline level by ASO treatment. The GFAP expression presented a different changing course tendency: increasing since day 3 and
keepingahighlevel 1 wafterSNL.Interestingly,theincreaseofGFAP expression wasinterferedwithbyASO treatment onday3 and7.#,P,0.05and#
#, P,0.01, as compared to the baseline value; *, P,0.05 and **, P,0.01, as compared to the saline control in the same time point. Scale bar=200 mm.
doi:10.1371/journal.pone.0006973.g004
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data suggest that neuronal activation emerges majorly in the
induction of mechanical allodynia. Fos is expressed in the nuclei of
nociceptive neurons following various noxious stimuli, thus serves
as a marker for activated neurons. Increased Fos immunoreactivity
directly reflects up-regulation in neuronal activity [19]. In our
present experiment, Fos expression reached a very high level 2 h
after SNL, and decreased quickly in a few days. Blocking Fos
expression significantly decreased the mechanical allodynia right
after the SNL. These data together, support that early increase of
Fos expression is very critical for the induction of mechanical
allodynia after SNL. Our point also gets literature supports in that
SNL induced an immediate (,10 min) but transient (,6h )
induction of phosphorylated extracellular regulated protein kinase
(pERK, marker for activated cells) restricted to neurons in the
SDH, while shutdown of these activated neurons attenuated the
mechanic allodynia [34].
Previous research suggested that glial cells take part in the
nociceptive process with the major focus on microglia [12]. Studies
on astrocytes either suggest a role downstream to microglia or less
Figure 5. The effects of L-AA on astrocytic activation and Fos expression in the ipsilateral dorsal horn induced by SNL. Compared to
the saline control group, L-AA produced a marked reduction of GFAP-positive astrocytes in the dorsal horn (A, A’). L-AA did not influence the
numbers of NeuN-expressing neurons indicating the specific role of this astroglial toxin (B, B’). How ever, it did significantly suppress the Fos
expression on POD 3 (C, C’). D, The changing course of astrocytic activation and Fos expression after L-AA administration to the SNL rats. The baseline
level of Fos and GFAP was set as 100%, respectively. The changing course of Fos (red curves) or GFAP (green curves) was determined with
comparison to the relative baseline value. L-AA postponed astrocytic activation from day 3 (saline control) to day 7. Meanwhile, this astroglial toxin
shortened the duration of Fos expression from 7 d (saline control) to 3 d post SNL, although it did not change the peak level of Fos expression. #,
P,0.05 and ## , P,0.01, as compared to the baseline value; *, P,0.05 and **, P,0.01, as compared to the saline control in the same time point.
Scale bar=200 mm.
doi:10.1371/journal.pone.0006973.g005
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spinal astrocytes were activated later than neurons, mainly in the
maintenance of mechanic allodynia after SNL. Actually, there are
still other reports that suggest a late involvement of astrocytic
activation in the maintenance of nociception [17,34].
Since neurons and astrocytes are integrated into the central
nervous system (CNS), it is not correct to discuss their contribution
to a certain function individually. The case for neuropathic pain is
also the same. Then the next question we want to ask is whether
these two major elements interact with each other for conveying
nociceptive information and how?
Neuronal activation is upstream to astrocytic activation
during neuropathic pain
Since neuronal activation is earlier than that of astrocytes, it is
natural to hypothesize that neuronal activation is upstream to
astrocytic activation. Our data also confirmed such relationship.
In our study, c-fos ASO was used to knockdown the expression
of Fos in vivo. Decreased expression of Fos was confirmed by
immunofluorescent evidence and was accompanied with de-
creased allodynia in the early stage. In agreement with our
previous study [24], c-fos ASO could inhibit c-fos activation in
parallel with the decreased allodynia induced by SNL. The most
remarkable inhibitory effect of c-fos ASO on allodynia is at the
early stage after SNL, which supports the above concept: c-fos
activation contributes more to the induction of allodynia. But a
very important finding is that: Fos up-regulation can not be
detected on POD 7 but c-fos ASO still influences allodynia at this
time point. So there must be some ‘‘c-fos-indirectly related’’ factors
contributing to the allodynia. Then we focused on the astrocytic
activation after c-fos ASO treatment on SNL rats.
Very interestingly, we observed that c-fos ASO suppressed
astrocytic activation after nerve injury. So there are at least two
explanations: one is that Fos is also expressed in astrocytes and c-
fos ASO inhibits astrocytic activation directly, and the other is that
Fos is mostly expressed in neurons and the effect of c-fos ASO on
astrocytes is indirect.
Though glial Fos expression was also observed in our
experiment (Fig. 3B’) and that of other investigators [36], the
quantity of glial Fos expression was extremely small compared to
neuronal population. We conclude that the inhibitory effect of c-fos
ASO appeared to focus directly on neurons, suppressing neuronal
activation, and further inhibiting the down stream astrocytic
response indirectly. Furthermore, c-fos ASO only inhibited
astrocytic activation but had little effect on astrocytes in their
‘‘silent’’ state, as shown by the invariant data for GFAP expression
early after nerve injury. This observation further supports our
hypothesis that the effect of c-fos ASO on astrocytic activation is an
indirect one.
Activated astrocytes enhance activation of their neuronal
counterparts
L-AA is a cytotoxin relatively specific for astrocytes. Ultrastruc-
tural evidence suggests that cell degeneration and death is confined
to astrocytes after the injection of L-AA into the striatum [37]. We
have also observed that L-AA did not influence the expression of
the neuronal marker NeuN. To examine whether spinal astrocytic
activation is important for neuronal activation, we administrated
L-AA intrathecally to SNL rats and detected Fos expression
afterward. This glial toxin did not affect Fos expression early
(,1 d) after nerve injury, however, it did shorten the duration of
Fos expression and this change is not because of neuronal loss after
L-AA application.
After chronic nerve lesions, Fos is usually expressed at an acute
situation, however, its decline with time is more variable and takes
much longer in different animal models. The underlying reason
for this dynamic is still unexplained [20]. Our results provide here
a possible reason that the duration of c-fos activation is likely
influenced by astrocytic activity. So the different activating levels
of astrocytes in pain states probably influence the dynamic of Fos
duration after nerve injury. So astrocytic activation not only
passively acts as the downstream of neuronal activation, but can
also enhance the upstream neuronal activation, thus a positive
feedback circuit probable exists between these two key elements in
the spinal cord during pain states.
A positive feedback circuit between spinal neurons and
astrocytes contributes to the SNL induced neuropathic
pain
Neuronal activation is followed by synthesis of various
transmitters like substance P (SP), excitatory amino acids, ATP
[38] and chemokines such as fractalkine [39]. Spinal astrocytic
activation is ‘‘triggered’’ by each of these transmitters via binding
to NK-1 receptors, metabotropic glutamate receptors, chemokine
receptors [40], as well as purinergic receptors [41] which are
expressed in astrocytes.
Receptor activation, in turn, leads to the consequent release of
neuroexcitatory substances, including prostaglandins, IL-1, IL-6,
and NO [42,43] from astrocytes. As a sort of proinflammatory
cytokines, interleukin-1 beta (IL-1b) is one of the most important
factors which is also the focus for our literature searching.
IL-1b mediates allodynia that has the underlied potentiated
neuronal nociceptive transmission [6,18,44]. Through binding
with its receptor on the neurons, IL-1b increases calcium
conductivity of neuronal NMDA receptor [45], possibly via
intracellular signaling pathways leading to the phosphorylation of
NMDA receptor NR1 subunit [6,44]. Previous study [46]
demonstrated that in pain state, most of the Fos is expressed in
NMDA receptor-containing neurons in spinal cord. A recent study
suggests that astrocyte-produced IL-1b may modulate Fos
expression during pain, and the interleukin-receptor antagonist
(interleukin-1ra) inhibits Fos expression and allodynia in rats [6].
Based on our literature review, a pathway of ‘‘astrocyte-IL-1b-
NMDAR-Fos’’ may exist.
Our results indicate that injury-induced Fos expression
immerges quickly, indicating a heightened activity of neurons
within the dorsal horn of the spinal cord. Neuronal hyperexcit-
ability in the pain-processing circuitry contributes to the central
sensitization [2,13]. Moreover, activated neurons synthesize and
release a variety of substances that ‘‘tell’’ spinal astrocytes to
activate [47]. And activated astrocytes also produce signaling
molecules (i.e. IL-1b) that can action back to modify neuronal
behavior, contributing to pain facilitation (Fig. 6).
While under ‘‘silent’’ conditions, astrocytes are primarily
involved in providing energy sources and neurotransmitter
precursors to neurons, cleaning up debris, regulating extracellular
levels of ions and neurotransmitters [14]. Astrocytes in this state,
only release very low levels of proinflammatory cytokines that is
not sufficient to activate the neurons. This is probably why in our
experiment, L-AA has no effect on Fos expression early after SNL.
However, we could not exclude the involvement of microglia in
this kind of crosstalk. Microglia play an important role in the
indirect interaction between neurons and astrocytes. We also
observed that in the present study, there was apparently no
astrocyte activation at 1-day post injury; yet lesions of astrocytes at
1 day attenuated neuronal activation as seen by Fos expression. It
is really very interesting. We think the most probable reason is that
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activity in some conditions. At the very early stage following nerve
injury (for hours), microglia activation is obviously observed when
astrocytic activation could not be detected. Microglia activity
could influence neuronal activation. So besides the direct
interaction, there is also indirect crosstalk between astrocytes
and neurons, via microglia.
In summary, we offer evidence for the reciprocal neuronal-
astrocytic signaling ‘‘dialog’’ underlying the mechanisms of neuro-
pathic pain. This positive feedbackcircuit enlargesthe effectof nerve
injuryonnociceptionandmakesitmoredifficultto develop aclinical
therapy for neuropathic pain [47]. These results further prove that
non-neural elements contribute to CNS activity-dependent neuronal
plasticity and behavioral hyperalgesia [13]. Said another way – they
emphasize neuronal and non-neuronal elements are integrally
related in nociceptive transmission, and that breaking this cycle of
interaction may offer novel pain treatment strategies.
Materials and Methods
Animals and surgical procedures
Male adult Sprague-Dawley rats (180–220 g) were housed in
plastic cages, three in each cage and maintained on a 12:12 h
light/dark cycle (light on at 6:00 and off at 18:00) under conditions
of 22–25uC ambient temperature with food and water available.
All experimental procedures received prior approval from the
Animal Use and Care Committee for Research and Education of
the Fourth Military Medical University (Xi’an, P. R. China) and
also the ethical guidelines to investigate experimental pain in
conscious animals [48]. All efforts were made to minimize animals’
suffering and to reduce the number of animals used.
Under pentobarbital anesthesia (45 mg/kg, i. p.), the left lumbar
5 (L5) transverse process was first removed to expose the L4 and L5
spinal nerves. The L5 spinal nerve was then carefully isolated and
tightly ligated with 6-0 silk thread [33]. The surgical procedure for
the sham group was identical to that of the SNL group, except that
spinal nerves were not ligated. For intrathecal drug administration,
a midline incision (3 cm) was made at the back of the rat at the level
of thoracic vertebrae 3–4. A polyethylene tube was introduced into
the subarachnoid space of the lumbar enlargement. The tube was
then brought out of the rat’s neck skin and secured in situ. The rats
were allowed to recover for a period of 3–5 d before further
investigation. Only the animals judged as neurologically normal
were used for the following experiments.
Administration of drugs
The phosphorothioate-modified c-fos oligodeoxynucleotides were
synthesized by Sangon Biotechnology Co. (Shanghai, China), and
the astroglial toxin L-AA was purchased from Sigma (St. Louis,
MO, USA). For c-fos oligodeoxynucleotides administration, the rats
were randomly assigned to three groups: (1) ASO group: rats
received i.t.injection ofc-fosASO(59-GAA CAT CATGGTCGT-
39) at a dose of 50 mgi n1 0ml normal saline (n=20); (2) SO group:
rats received i. t. injection of c-fos sense oligodeoxynucleotide (SO,
59-ACG ACC ATG ATG TTC-39) at a dose of 50 mgi n1 0ml
normal saline (n=12); (3) Saline group: rats received i. t. injection of
rats with i. t. normal saline (NS, 10 ml, n=12). For L-AA
administration (n=20), a dose of 100 nmol in 10 ml saline was i. t.
injected,usingnormal saline (10 ml, n=12) asa vehiclecontrol. The
drugs/saline were administrated daily at 4 h prior to the surgery, 1,
2, and 3 post-operation day (POD) (Fig. 7). For each injection, the
solution was slowly injected within 5 min and the needle was kept
for 1 more min so as to avoid the damage to the spinal cord.
Behavioral tests
To observe how different treatments affect the allodynia,
behavioraltestswereperformed 1 d beforethe drugsadministration
to provide baseline scores, and then from 4 h after SNL and for 1 w
(once a day) to evaluate the gradual changes in the mechanical
threshold of the rats. Briefly, the animals were habituated to the
testing environment for 3 d before baseline testing. Animals were
then putunderinverted plasticboxes(30 cm630 cm650 cm)onan
elevated mesh floor and allowed to habituate for 30 min before the
threshold testing. Mechanical threshold was tested using von Frey
filaments (Stoelting, Kiel, WI, USA) in a blinded manner. The
ipsilateral hind paw was pressed with one of a series of von Frey
filaments with gradually increasing stiffness (2, 4, 6, 8, 10, 15, and
26 g) appliedto the plantarsurfacefor5–6 s foreach filament.Each
filament was applied 10 times and the minimal value which caused
at least 6 responses was recorded as the paw withdrawal thresholds
(PWTs). Acute withdrawal, biting, licking or shaking of the
ipsilateral hind limb and vocalization were considered to be positive
signs of withdrawal [49].
Immunofluorescent staining
Animals were sacrificed at different time points (2 h, 1 d, 3 d,
7 d) after SNL. Under anesthesia with pentobarbital (60 mg/kg, i.
p.), the rats were perfused through the ascending aorta with 100 ml
of normal saline followed by 500 ml of 0.1 M phosphate buffer (PB,
pH 7.3)containing 4% paraformaldehydeand 2%picricacid. After
the perfusion, the L5 spinal segment was removed and postfixed in
the same fixative for 2–4 h and then cryoprotected for 24 h at 4uC
in 0.1 M PB containing 30% sucrose.
Figure 6. Schematic illustration of the positive feedback circuit
between spinal neurons and astrocytes in neuropathic pain
state. After peripheral nerve injury, various transmitters like substance
P (SP), excitatory amino acids (EAA), were released from the presynaptic
terminals in the superficial dorsal horn, which caused immediate (in
hours) neuronal activation in the spinal dorsal horn. Neuronal activation
is followed by a higher degree of synthesis and release of excitatory
transmitters, which triggered late (.3 d) astrocytic activation. Activated
astrocytes also produced neuroexcitatory substances, like IL-1b, IL-6,
NO, and so on. These neuroexcitatory substances could action back to
modify neuronal behavior, contributing to pain facilitation.
doi:10.1371/journal.pone.0006973.g006
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a cryostat, collected serially into two dishes. Each dish contained a
complete set of serial sections which were then processed for
immunofluorescent staining. All of the sections in the first dish
were rinsed in 0.01 M phosphate-buffered saline (PBS, pH 7.3) for
three times (10 min each), blocked with 2% goat serum in 0.01 M
PBS containing 0.3% Triton X-100 for 1 h at the room
temperature (RT) and then used for immunofluorescent staining.
The sections were incubated overnight at 4uC with primary
antibodies: mouse anti-glial fibrillary acidic protein (GFAP)
(1:5000; Chemicon, Temecula, CA, USA), rabbit anti-Fos
(1:1000; Santa Cruz Biotechnology, Calif., USA) and mouse
anti-NeuN (1:3000; Chemicon), respectively. The sections were
then washed for three times in 0.01 M PBS (10 min each) and
then incubated for 2 h at RT with the mixture of respective
secondary antibodies: FITC-conjugated horse anti-mouse IgG
(1:200; Vector, Burlingame, CA, USA) and Alexa 594-conjugated
donkey anti-rabbit IgG (1:800; Molecular Probes, Rockford, IL,
USA). For double immunofluorescence of Fos/GFAP and Fos/
NeuN, sections were incubated with a mixture of two primary
antibodies, followed by a mixture of the two respective secondary
antibodies. The specificities of the staining were tested on the
sections in the second dish by omission of the specific primary
antibodies. No immunoreactive products were found on the
sections (data not shown). Images were obtained using a confocal
laser microscope (FV1000; Olympus, Tokyo, Japan) and Digital
images were captured with Fluoview 1000 (Olympus).
Quantification and statistical analysis
Five nonadjacent sections from the L5 segments were selected
randomly. In each group, 3 rats were used for statistical analysis. So
in each group, there were 30 sections obtained for histology
quantifications. Images were evaluated by a computer-assisted image
analysis program (MetaMorph 6.1). To measure the area of GFAP
immunopositive somata, we used the Threshold Image function in
Measure of MetaMorph 6.1 to set the low and high thresholds for the
immunofluorescent intensity which was determined to be a signal.
Our image data were collected using the same region and the same
size of field within same lamina to avoid any variance and difference
in staining between laminae. The same configuration was used to
measure cell areas in all experimental groups. The measured areas
were transferred to Excel automatically for the following statistic
analysis. MetaMorph 6.1 is calibrated to provide standardization of
areameasurements.Astandardizedfieldareawassampledarbitrarily
from regions within randomly selected dorsal horn sections. And the
numbers of Fos-positive cells of the same areas were counted. Then
the immunoreactivities for GFAP and total numbers of Fos-
immunopositive cells within the superficial dorsal horn were
averaged across the five spinal sections for each experimental group
[17]. Fos and NeuN double labeled neurons on the ipsilateral
superficial dorsal horn were counted and the proportion of double
labeled neurons to total Fos positive cells was then calculated.
All behavioral data and morphological data were colleted by
experimenters blinded to the surgery and reagents treatments and
statistical analyses were done by using SPSS software (version 10).
Data were expressed as mean 6 standard error mean (mean6-
S.E.M.). Two-way analysis of variance (ANOVA) (Group6Day)
was used for analysis of behavioral data as well as morphological
analysis. Dunnett’s C post hoc test, assuming the variances were not
equal, was employed whenever appropriate and significance was
set at 0.05 for all statistical tests.
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